Research progress in radiotherapy combined with immunotherapy for non-small cell lung cancer
10.3760/cma.j.issn.1004-4221.2018.05.020
- VernacularTitle:NSCLC放疗联合免疫治疗研究进展
- Author:
Meng YUAN
1
;
Yu MEN
;
Zhouguang HUI
Author Information
1. 国家癌症中心/中国医学科学院北京协和医学院肿瘤医院放疗科
- Keywords:
Carcinoma,non-small cell lung/radiotherapy;
Carcinoma,non-small cell lung/immunotherapy;
Research progress
- From:
Chinese Journal of Radiation Oncology
2018;27(5):533-537
- CountryChina
- Language:Chinese
-
Abstract:
Radiotherapy is the common traditional treatment for non-small cell lung cancer (NSCLC).In recent years,remarkable advances have been made in immunotherapy,especially the use of immune checkpoint inhibitors.How to effectively combine radiotherapy and immunotherapy to maximize the benefit for patients has become a hot topic in clinical research.This article expounds recent research progress in immunotherapy for NSCLC,the effect of radiotherapy on tumor immunology,and the advances and challenges in radiotherapy combined with immunotherapy for NSCLC.
